Back

Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters Arrhythmogenic Right Ventricular Cardiomyopathy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Deniz Akdis

University Heart Center, Zurich (Switzerland)

34 More presentations in this session

Presentation thumbnail
Usefulness of late gadolinium enhancement cardiac magnetic resonance to predict appropriate therapies in implantable cardioverter defibrillator patients in primary prevention
Miss P. Sanchez Somonte (Girona, ES)
Abstract Slides
Presentation thumbnail
Incidence of sudden cardiac death after heart transplantation
Doctor G. Bonnet (Bordeaux, FR)
Abstract Slides
Presentation thumbnail
Idiopathic HFrEF. Is there room left for defibrillators?
Doctor F. Fernandes Gama (Carnaxide, PT)
Abstract Slides
Presentation thumbnail
Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy
Doctor N. Parashar (Delhi, IN)
Abstract Slides
Presentation thumbnail
Arrhythmogenic cardiomyopathy is characterized by apex-to-base heterogeneity of right ventricular myocardial contractility and stiffness: an imaging-based patient-specific modeling study
Mr N. van Osta (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease
thumbnail
Congress Presentation
Arrhythmogenic cardiomyopathy
thumbnail
Congress Session
Risk assessment and prevention of sudden cardiac death in cardiomyopathies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources